Literature DB >> 7758944

Relief of YY1 transcriptional repression by adenovirus E1A is mediated by E1A-associated protein p300.

J S Lee1, K M Galvin, R H See, R Eckner, D Livingston, E Moran, Y Shi.   

Abstract

YY1 represses transcription when bound upstream of transcriptional initiation sites. This repression can be relieved by adenovirus E1A. Here, we present genetic evidence that the ability of E1A to relieve YY1 repression was impaired by mutations that affect E1A binding to its associated protein p300. This suggests that E1A may modulate the repressor activity of YY1 by binding to p300, which may be physically complexed with YY1. A YY1/p300 protein complex in vivo was demonstrated by several independent approaches, and the YY1-interacting domain was mapped to the carboxy-terminal region of p300, distinct from the E1A-binding site. Unlike E2F/RB, the YY1/p300 complex is not disrupted by E1A. Functional studies using recombinant p300 demonstrated unequivocally that p300 is capable of mediating E1A-induced transcriptional activation through YY1. Taken together, these results reveal, for the first time, a YY1/p300 complex that is targeted by E1A and demonstrate a function for p300 in mediating interactions between YY1 and E1A. Our data thus identify YY1 as a partner protein for p300 and uncover a molecular mechanism for the relief of YY1-mediated repression by E1A.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7758944     DOI: 10.1101/gad.9.10.1188

Source DB:  PubMed          Journal:  Genes Dev        ISSN: 0890-9369            Impact factor:   11.361


  120 in total

1.  A specific lysine in c-Jun is required for transcriptional repression by E1A and is acetylated by p300.

Authors:  R G Vries; M Prudenziati; C Zwartjes; M Verlaan; E Kalkhoven; A Zantema
Journal:  EMBO J       Date:  2001-11-01       Impact factor: 11.598

2.  Repression of c-Myc and inhibition of G1 exit in cells conditionally overexpressing p300 that is not dependent on its histone acetyltransferase activity.

Authors:  Sudhakar Baluchamy; Hasan N Rajabi; Rama Thimmapaya; Arunasalam Navaraj; Bayar Thimmapaya
Journal:  Proc Natl Acad Sci U S A       Date:  2003-07-25       Impact factor: 11.205

3.  Interaction and functional collaboration of p300 and C/EBPbeta.

Authors:  S Mink; B Haenig; K H Klempnauer
Journal:  Mol Cell Biol       Date:  1997-11       Impact factor: 4.272

4.  Selective induction of p53 and chemosensitivity in RB-deficient cells by E1A mutants unable to bind the RB-related proteins.

Authors:  A V Samuelson; S W Lowe
Journal:  Proc Natl Acad Sci U S A       Date:  1997-10-28       Impact factor: 11.205

5.  Interaction of the co-activator CBP with Myb proteins: effects on Myb-specific transactivation and on the cooperativity with NF-M.

Authors:  M Oelgeschläger; R Janknecht; J Krieg; S Schreek; B Lüscher
Journal:  EMBO J       Date:  1996-06-03       Impact factor: 11.598

6.  Adenovirus transforming protein E1A induces c-Myc in quiescent cells by a novel mechanism.

Authors:  Ravi-Kumar Kadeppagari; Natesan Sankar; Bayar Thimmapaya
Journal:  J Virol       Date:  2009-03-11       Impact factor: 5.103

7.  Insulin gene transcription is mediated by interactions between the p300 coactivator and PDX-1, BETA2, and E47.

Authors:  Yi Qiu; Min Guo; Suming Huang; Roland Stein
Journal:  Mol Cell Biol       Date:  2002-01       Impact factor: 4.272

Review 8.  Regulation of serum amyloid A protein expression during the acute-phase response.

Authors:  L E Jensen; A S Whitehead
Journal:  Biochem J       Date:  1998-09-15       Impact factor: 3.857

9.  Multilayered chromatin analysis reveals E2f, Smad and Zfx as transcriptional regulators of histones.

Authors:  David Gokhman; Ilana Livyatan; Badi Sri Sailaja; Shai Melcer; Eran Meshorer
Journal:  Nat Struct Mol Biol       Date:  2012-12-09       Impact factor: 15.369

10.  Influence of promoter potency on the transcriptional effects of YY1, SRF and Msx-1 in transient transfection analysis.

Authors:  T Lee; M E Bradley; J L Walowitz
Journal:  Nucleic Acids Res       Date:  1998-07-01       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.